CytoSorbents

CytoSorbents CytoSorbents Corporation is a critical care focused immunotherapy company using blood purification t

CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology. CytoSorbents is a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is distributed in more than 70 countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery. CytoSorbents has multiple active, clinical trials ongoing, including two pivotal randomized, controlled trials in the United States designed to support eventual FDA marketing approval for antithrombotic removal during cardiothoracic surgery using the DrugSorb™-ATR Antithrombotic Removal System.

🤝 We are pleased to announce the extension of our long-standing partnership with Aferetica S.r.L., our trusted distribut...
03/19/2026

🤝 We are pleased to announce the extension of our long-standing partnership with Aferetica S.r.L., our trusted distribution partner for CytoSorb® in Italy and PerSorb, for ex situ organ perfusion worldwide.

✍️ Today, we officially signed the renewal of our agreement, reaffirming our shared commitment to advancing patient care and expanding access to our technology across the Italian market.

Over the years, Aferetica has demonstrated exceptional dedication, expertise, and alignment with our mission. We look forward to continuing this successful collaboration and further strengthening our presence together.

💫 Here’s to the next chapter of our partnership! Aferetica

Happening now at ISICEM 2026 in Brussels 🇧🇪Our symposium is underway, bringing together international experts to discuss...
03/19/2026

Happening now at ISICEM 2026 in Brussels 🇧🇪

Our symposium is underway, bringing together international experts to discuss current perspectives and clinical experiences with CytoSorb therapy in critical care.

The session focuses on practical insights from clinical practice, real-world experiences, and the evolving role of extracorporeal blood purification in the management of critically ill patients.

💐 A big thank you to our distinguished faculty and everyone joining us for the discussion. We are excited to see such strong interest and engagement.

👋 If you are attending ISICEM 2026, feel free to stop by our booth by the Silver Foyer afterwards to continue the conversation.

✨ 📣 Jetzt die Aufzeichnung ansehen!Unser Webinar „Der Grundsatz der evidenzbasierten Medizin“ ist online verfügbar.Exper...
03/18/2026

✨ 📣 Jetzt die Aufzeichnung ansehen!
Unser Webinar „Der Grundsatz der evidenzbasierten Medizin“ ist online verfügbar.

Expert:innen:
• Dr. iur. Christian Rybak (Greenberg Traurig, Germany LLP)
• Dr. med. Volker Humbert und Franziska Preissing (CytoSorbents Europe GmbH)

🎥 Zur Aufzeichnung: https://cyto.news/medcon/mar2026

Hello from ISICEM 2026 in Brussels 🇧🇪The congress has just kicked off, and we are excited to be here for the next few da...
03/17/2026

Hello from ISICEM 2026 in Brussels 🇧🇪

The congress has just kicked off, and we are excited to be here for the next few days of inspiring discussions, new insights, and great conversations in critical care.

Our team is on site and ready to welcome visitors at our booth by the Silver Foyer. Stop by to meet, exchange ideas, and get a closer look at what we are working on.

What you can discover at our booth:
• Learn more about the clinical insights and applications of CytoSorb therapy
• Take a closer look at PuriFi, designed for standalone CytoSorb application
• Explore HotSwap, our new system enabling seamless CytoSorb exchange

We are looking forward to connecting with you over the coming days.
See you at ISICEM! 👋

ISICEM 2026 – Let’s connect in BrusselsJoin our team at the 45th International Symposium on Intensive Care and Emergency...
03/12/2026

ISICEM 2026 – Let’s connect in Brussels
Join our team at the 45th International Symposium on Intensive Care and Emergency Medicine and see how we are shaping the future of blood purification in critical care.

What to expect at our booth by the Silver Foyer:
✔️ Gain in-depth insights into CytoSorb therapy
✔️ Explore PuriFi – designed for standalone CytoSorb application
✔️ Discover HotSwap – the new system for seamless CytoSorb exchange

🎓 Planning to attend our symposium on Thursday? Save the Date:
• March 19, 2026
• 12:30-13:30 CET
• Copper Hall
• Program: https://cytosorbents.com/event/45-isicem/

👋 See you in Brussels - we look forward to connecting!

🌍 World Kidney DayEvery day, our kidneys filter approximately 190 liters of blood. Their health is essential for keepin...
03/12/2026

🌍 World Kidney Day
Every day, our kidneys filter approximately 190 liters of blood. Their health is essential for keeping our bodies in balance — yet certain medical conditions can put them under serious stress.

One critical example is rhabdomyolysis, where the breakdown of muscle tissue releases myoglobin into the bloodstream. High levels of myoglobin can accumulate in the kidneys and could be linked to acute kidney injury (AKI). In these clinical situations, hemoadsorption may be used to remove myoglobin and help to restore kidney function. Learn more at https://cytosorbents.com/kidney/

World Kidney Day is a reminder of the importance of raising awareness for conditions that can compromise kidney function — and of various approaches that help protect kidneys in critical care. At CytoSorbents, we are dedicated to supporting therapies that make this possible.

Learn more about the 2026 World Kidney Day and join the campaign: https://www.worldkidneyday.org/2026-campaign/

🕒 Morgen um 15 Uhr ist es soweit: Die nächste Folge unserer Webinarreihe „Medizincontrolling: Wissen kompakt“ steht bevo...
03/10/2026

🕒 Morgen um 15 Uhr ist es soweit: Die nächste Folge unserer Webinarreihe „Medizincontrolling: Wissen kompakt“ steht bevor.

📚 Thema: Der Grundsatz der evidenzbasierten Medizin

• Nutzen, Zusatznutzen und Potential im Kontext des SGB V: Voraussetzung für eine Erstattungsfähigkeit? Dr. iur. Christian Rybak, Partner/Shareholder, Chair Health Care & Life Sciences Germany, Greenberg Traurig, Germany LLP

• Diskussion praktischer Fälle am Beispiel der Hämoadsorption mit CytoSorb
Dr. med. Volker Humbert und Franziska Preissing, CytoSorbents Europe GmbH

Den Link zur Anmeldung finden Sie hier:
👉 https://cyto.news/medcon/mar2026

👉 many of the foundations of modern healthcare were shaped by remarkable women? From nursing and surgery to public hea...
03/08/2026

👉 many of the foundations of modern healthcare were shaped by remarkable women? From nursing and surgery to public health and psychology, generations of women have led groundbreaking advances that continue to improve lives worldwide.

🗓️ This International Women’s Day, we celebrate the pioneers who paved the way - and the women shaping the future of healthcare today.

👏 💐 Happy International Women’s Day 2026.

🏆 Wissenschaftliche Exzellenz verdient besondere Anerkennung: Im Rahmen des "36. Symposiums Intensivmedizin + Intensivpf...
03/03/2026

🏆 Wissenschaftliche Exzellenz verdient besondere Anerkennung: Im Rahmen des "36. Symposiums Intensivmedizin + Intensivpflege" in Bremen wurde der renommierte Hanse-Promotionspreis vergeben.

Der Hanse-Promotionspreis 2026 für Experimentelle Forschung in der Intensiv- und Notfallmedizin, gestiftet von der CytoSorbents Europe GmbH, ging an Dr. rer. nat. Mirko Sonntag, Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB, für seine herausragende Promotionsarbeit:

„Cell-free DNA as biomarker molecule to assess sepsis from a diagnostic point of view“

👏 Wir gratulieren Dr. Sonntag herzlich zu dieser Auszeichnung und danken allen Preisträger:innen für ihren wichtigen Beitrag zur Weiterentwicklung der Intensiv- und Notfallmedizin.



(v. li.) Prof. Dr. Rolf Dembinski (Klinikum Bremen-Mitte), Dr. rer. nat. Mirko Sonntag (Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB), Sabrina Dübon (CytoSorbents Europe GmbH). Prof. Dr. Dorothee Bremerich (Klinikum Lippe gGmbH)

Address

305 College Road East
Princeton, NJ
08540

Website

Alerts

Be the first to know and let us send you an email when CytoSorbents posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CytoSorbents:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category